SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hiroshi Kataoka, Nobuhiro Sawa, Kazuma Sugie, Satoshi Ueno, Can dopamine agonists trigger tactile hallucinations in patients with Parkinson's disease?, Journal of the Neurological Sciences, 2014,

    CrossRef

  2. 2
    Martin Broadstock, Clive Ballard, Anne Corbett, Novel pharmaceuticals in the treatment of psychosis in Parkinson’s disease, Expert Review of Clinical Pharmacology, 2014, 7, 6, 779

    CrossRef

  3. 3
    M. Kuoppamäki, M. Vahteristo, J. Ellmén, K. Kieburtz, Pooled analysis of phase III with entacapone in Parkinson's disease, Acta Neurologica Scandinavica, 2014, 130, 4
  4. 4
    Kangdi Zhu, Jacobus J. van Hilten, Johan Marinus, Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG, Parkinsonism & Related Disorders, 2014, 20, 9, 980

    CrossRef

  5. 5
    Michal Lubomski, R. Louise Rushworth, Will Lee, Kelly L. Bertram, David R. Williams, Sex differences in Parkinson’s disease, Journal of Clinical Neuroscience, 2014, 21, 9, 1503

    CrossRef

  6. 6
    H. Baas, J. Claßen, M. Gerlach, M. Schwarz, P. Themann, D. Woitalla, W. Jost, Should the maximum daily doses of levodopa be limited to 400mg/die?, Basal Ganglia, 2014, 4, 1, 29

    CrossRef